329 related articles for article (PubMed ID: 14581370)
1. Bombesin/gastrin-releasing peptide receptor: a potential target for antibody-mediated therapy of small cell lung cancer.
Zhou J; Chen J; Mokotoff M; Zhong R; Shultz LD; Ball ED
Clin Cancer Res; 2003 Oct; 9(13):4953-60. PubMed ID: 14581370
[TBL] [Abstract][Full Text] [Related]
2. Targeting gastrin-releasing peptide receptors on small cell lung cancer cells with a bispecific molecule that activates polyclonal T lymphocytes.
Zhou J; Chen J; Zhong R; Mokotoff M; Shultz LD; Ball ED
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2224-31. PubMed ID: 16609038
[TBL] [Abstract][Full Text] [Related]
3. Antitumoral activity of bombesin analogues on small cell lung cancer xenografts: relationship with bombesin receptor expression.
Thomas F; Arvelo F; Antoine E; Jacrot M; Poupon MF
Cancer Res; 1992 Sep; 52(18):4872-7. PubMed ID: 1325285
[TBL] [Abstract][Full Text] [Related]
4. [Psi 13,14] bombesin analogues inhibit growth of small cell lung cancerin vitro and in vivo.
Mahmoud S; Staley J; Taylor J; Bogden A; Moreau JP; Coy D; Avis I; Cuttitta F; Mulshine JL; Moody TW
Cancer Res; 1991 Apr; 51(7):1798-802. PubMed ID: 1848479
[TBL] [Abstract][Full Text] [Related]
5. Selective stimulation of small cell lung cancer clonal growth by bombesin and gastrin-releasing peptide.
Carney DN; Cuttitta F; Moody TW; Minna JD
Cancer Res; 1987 Feb; 47(3):821-5. PubMed ID: 3026617
[TBL] [Abstract][Full Text] [Related]
6. Chimeric and humanized anti-HM1.24 antibodies mediate antibody-dependent cellular cytotoxicity against lung cancer cells.
Wang W; Nishioka Y; Ozaki S; Jalili A; Verma VK; Hanibuchi M; Abe S; Minakuchi K; Matsumoto T; Sone S
Lung Cancer; 2009 Jan; 63(1):23-31. PubMed ID: 18524412
[TBL] [Abstract][Full Text] [Related]
7. A novel vaccine targeting gastrin-releasing peptide: efficient inhibition of breast cancer growth in vivo.
Guojun W; Wei G; Kedong O; Yi H; Yanfei X; Qingmei C; Yankai Z; Jie W; Hao F; Taiming L; Jingjing L; Rongyue C
Endocr Relat Cancer; 2008 Mar; 15(1):149-59. PubMed ID: 18310283
[TBL] [Abstract][Full Text] [Related]
8. Production of neuromedin B and neuromedin B gene expression in human lung tumor cell lines.
Cardona C; Rabbitts PH; Spindel ER; Ghatei MA; Bleehen NM; Bloom SR; Reeve JG
Cancer Res; 1991 Oct; 51(19):5205-11. PubMed ID: 1717141
[TBL] [Abstract][Full Text] [Related]
9. Effects of bombesin antagonists on the growth of small cell lung cancer cells in vitro.
Layton JE; Scanlon DB; Soveny C; Morstyn G
Cancer Res; 1988 Sep; 48(17):4783-9. PubMed ID: 2457430
[TBL] [Abstract][Full Text] [Related]
10. Effects of bombesin on human small cell lung cancer cells: evidence for a subset of bombesin non-responsive cell lines.
Kado-Fong H; Malfroy B
J Cell Biochem; 1989 Aug; 40(4):431-7. PubMed ID: 2550492
[TBL] [Abstract][Full Text] [Related]
11. Effects of neuropeptide analogues on calcium flux and proliferation in lung cancer cell lines.
Bunn PA; Chan D; Stewart J; Gera L; Tolley R; Jewett P; Tagawa M; Alford C; Mochzuki T; Yanaihara N
Cancer Res; 1994 Jul; 54(13):3602-10. PubMed ID: 7516822
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody SEN7 recognizes a new epitope on the neural cell adhesion molecule present on small cell lung cancer but not on lymphocytes.
Waibel R; Mannhart M; O'Hara CJ; Brocklehurst C; Zangemeister-Wittke U; Schenker T; Lehmann HP; Weber E; Stahel RA
Cancer Res; 1993 Jun; 53(12):2840-5. PubMed ID: 7684948
[TBL] [Abstract][Full Text] [Related]
13. Human CD4+ effector T cells mediate indirect interleukin-12- and interferon-gamma-dependent suppression of autologous HLA-negative lung tumor xenografts in severe combined immunodeficient mice.
Egilmez NK; Hess SD; Chen FA; Takita H; Conway TF; Bankert RB
Cancer Res; 2002 May; 62(9):2611-7. PubMed ID: 11980657
[TBL] [Abstract][Full Text] [Related]
14. Reduction in receptors for bombesin and epidermal growth factor in xenografts of human small-cell lung cancer after treatment with bombesin antagonist RC-3095.
Halmos G; Schally AV
Proc Natl Acad Sci U S A; 1997 Feb; 94(3):956-60. PubMed ID: 9023364
[TBL] [Abstract][Full Text] [Related]
15. Androgen-dependent expression of the gastrin-releasing peptide receptor in human prostate tumor xenografts.
de Visser M; van Weerden WM; de Ridder CM; Reneman S; Melis M; Krenning EP; de Jong M
J Nucl Med; 2007 Jan; 48(1):88-93. PubMed ID: 17204703
[TBL] [Abstract][Full Text] [Related]
16. Evidence for autocrine actions of neuromedin B and gastrin-releasing peptide in non-small cell lung cancer.
Siegfried JM; Krishnamachary N; Gaither Davis A; Gubish C; Hunt JD; Shriver SP
Pulm Pharmacol Ther; 1999; 12(5):291-302. PubMed ID: 10545285
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of antagonists of bombesin and growth hormone-releasing hormone on orthotopic and intraosseous growth and invasiveness of PC-3 human prostate cancer in nude mice.
Stangelberger A; Schally AV; Varga JL; Zarandi M; Szepeshazi K; Armatis P; Halmos G
Clin Cancer Res; 2005 Jan; 11(1):49-57. PubMed ID: 15671527
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of bombesin receptor antagonist RC-3095 on the growth of human pancreatic cancer cells in vivo and in vitro.
Qin Y; Ertl T; Cai RZ; Halmos G; Schally AV
Cancer Res; 1994 Feb; 54(4):1035-41. PubMed ID: 8313359
[TBL] [Abstract][Full Text] [Related]
19. Effective inhibition of experimental human ovarian cancers with a targeted cytotoxic bombesin analogue AN-215.
Engel JB; Keller G; Schally AV; Halmos G; Hammann B; Nagy A
Clin Cancer Res; 2005 Mar; 11(6):2408-15. PubMed ID: 15788692
[TBL] [Abstract][Full Text] [Related]
20. Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines in vitro and in vivo and produces synergistic growth inhibition in combination with other antitumor agents.
Chan DC; Gera L; Stewart JM; Helfrich B; Zhao TL; Feng WY; Chan KK; Covey JM; Bunn PA
Clin Cancer Res; 2002 May; 8(5):1280-7. PubMed ID: 12006549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
